Pages that link to "Q38888541"
Jump to navigation
Jump to search
The following pages link to The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines. (Q38888541):
Displaying 8 items.
- Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition (Q37699405) (← links)
- Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation. (Q48182143) (← links)
- Targeted Therapy for Medullary Thyroid Cancer: A Review (Q49328959) (← links)
- Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer (Q49468702) (← links)
- 8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth. (Q51615486) (← links)
- Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis (Q90705767) (← links)
- Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy (Q90731220) (← links)
- Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth (Q91411280) (← links)